Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Abbvie Inc (ABBV) Ordinary Shares USD 0.01

Sell:$94.03 Buy:$94.05 Change: $1.30 (1.36%)
Market closed |  Prices as at close on 14 February 2020 | Switch to live prices |
Sell:$94.03
Buy:$94.05
Change: $1.30 (1.36%)
Market closed |  Prices as at close on 14 February 2020 | Switch to live prices |
Sell:$94.03
Buy:$94.05
Change: $1.30 (1.36%)
Market closed |  Prices as at close on 14 February 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).

Contact details

Address:
1 N Waukegan Rd
NORTH CHICAGO
60064-1802
United States
Telephone:
+1 (847) 9327900
Website:
https://www.abbvie.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ABBV
ISIN:
US00287Y1091
Market cap:
$139.09 billion
Shares in issue:
1.48 billion
Sector:
Biotechnology
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Richard Gonzalez
    Chairman of the Board, Chief Executive Officer
  • Michael Severino
    President, Vice Chairman
  • Carlos Alban
    Vice Chairman, Chief Commercial Officer
  • Laura Schumacher
    Vice Chairman, External Affairs and Chief Legal Officer
  • Robert Michael
    Chief Financial Officer, Senior Vice President
  • Timothy Richmond
    Chief Human Resource Officer, Executive Vice President
  • William Chase
    Executive Vice President - Finance and Administration
  • Henry Gosebruch
    Executive Vice President, Chief Strategy Officer
  • Azita Saleki-Gerhardt
    Executive Vice President - Operations
  • Nicholas Donoghoe
    Senior Vice President - Enterprise Innovation

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.